JB Bio 2 ApS: Financial statements 2025
CVR: 41041722
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
JB Bio 2 ApS (CVR 41041722) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -58,700 and a net result of DKK -7,715,676 compared with DKK 27,177,154 the year before. Equity in the 2025 report amounted to DKK 17,959,153. The solvency ratio was 99.9%.
- Gross Profit
- DKK -58,700
- Profit/Loss
- DKK -7,715,676
- Equity
- DKK 17,959,153
- Total Assets
- DKK 17,972,840
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -59 t. | -7.7 mio. | 18 mio. | 0 |
| 2024 | - | -6 t. | 27.2 mio. | 27.2 mio. | - |
| 2023 | - | -5 t. | -5 t. | -2 t. | - |
| 2022 | - | -5 t. | -5 t. | 3 t. | 0 |
| 2021 | - | -7 t. | -27 t. | 7 t. | - |
Official annual report
How creditworthy is JB Bio 2 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
JB Bio 2 ApS has published its annual report for 2024. Gross profit came to DKK -5,501, and the net result was DKK 27,177,154.
About JB Bio 2 ApS
JB Bio 2 ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jannick Dyrløv Bendtsen. The company is owned by Jannick Dyrløv Bendtsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -58,700 and a net result of DKK -7,715,676 compared with DKK 27,177,154 the year before. Equity in the 2025 report amounted to DKK 17,959,153.